The Society of Nuclear Medicine and Molecular Imaging (SNMMI) held its 2020 Virtual Annual Meeting on July 11–14, during which officers for the current term were elected, including Alan B. Packard, PhD, as President, and Richard L. Wahl, MD, as President-Elect.
“SNMMI’s strength comes from its breadth of membership, with physicians, scientists, and technologists working together to advance nuclear medicine and molecular imaging in order to provide patients with the best possible care,” Dr. Packard noted. “This is a very exciting time for the field of nuclear medicine, and as President of SNMMI, I look forward to working with my fellow members to build upon recent breakthroughs in the field, especially in the area of theranostics, and to demonstrating the value of nuclear medicine to those outside our field.”
Dr. Packard is Associate Professor of Radiology at Harvard Medical School, Director of Radiopharmaceutical Research, and Senior Research Associate in Nuclear Medicine at Boston Children’s Hospital. His overall goal for the coming year is to expand the value of SNMMI membership by enhancing its core benefits—the SNMMI Annual Meeting, continuing education, and The Journal of Nuclear Medicine—and to strengthen the society and field by promoting nuclear medicine and molecular imaging to the medical community, regulators, patients, and the public.
Dr. Wahl is the Elizabeth E. Mallinckrodt Professor and Head of Radiology at Washington University School of Medicine in St. Louis, Director of the University’s Mallinckrodt Institute of Radiology, and Professor of Radiation Oncology.
“Nuclear medicine is undergoing a renaissance as a precision medicine specialty, with new radiopharmaceuticals, theranostics, and instrumentation to elucidate biology and benefit patients,” Dr. Wahl stated. During his time in office, he plans to focus on access to and advocacy for nuclear medicine, increasing the diversity and number of professionals working in nuclear medicine, and discovery and innovation in nuclear medicine science.